Nilesh Gokal, MD
Family Medicine · Las Vegas, NVNPI 1164653432
Payments from drug & device makers
What this record shows
The money is spread across several categories — speaking fees (47.7%), consulting fees and travel and lodging — rather than concentrated in one kind of arrangement. Exact Sciences accounts for 78.5% of it on its own, with 11 other manufacturers making up the rest. 2025 is the largest year on record at $54,940, more than ten times the $357 reported in 2019. Among family medicine clinicians in NV with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 240 payments — averaging $311.39 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Exact Sciences$59K
- Daiichi Sankyo Inc.$12K
- Novo Nordisk$3K
- Boehringer Ingelheim$555
- AstraZeneca$532
- Pfizer$218
- plus $209 from 6 others
What the payments were for
- Consulting fees$22,28430%
- Speaking & faculty fees$35,68048%
- Travel & lodging$14,07819%
- Food & beverage$2,6594%
- Education$320%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Exact Sciences | 177 | $58,629 |
| Daiichi Sankyo Inc. | 13 | $11,583 |
| Novo Nordisk | 13 | $3,007 |
| Boehringer Ingelheim | 10 | $555 |
| AstraZeneca | 4 | $532 |
| Pfizer | 11 | $218 |
| GSK | 3 | $61 |
| Merck | 2 | $40 |
| Johnson & Johnson | 3 | $38 |
| Dexcom, Inc. | 2 | $36 |
| Medtronic | 1 | $22 |
| Sanofi-aventis U.S. LLC | 1 | $11 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- The Cologuard Plus Collection Kit$43,863
- Cologuard Collection Kit$11,744
- INJECTAFER$8,923
- AIRSUPRA$500
- JARDIANCE$243
- JASCAYD$124
How this compares
$74,733 in reported general payments places this provider in the 95th percentile of 902 family medicine providers in Nevada.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| EliquisApixaban | 54 | $69,174 |
| OzempicSemaglutide | 32 | $50,947 |
| JardianceEmpagliflozin | 40 | $45,879 |
| TriumeqAbacavir/Dolutegravir/Lamivudi | 11 | $41,437 |
| Trelegy ElliptaFluticasone/Umeclidin/Vilanter | 12 | $14,677 |
| Soliqua 100-33Insulin Glargine/Lixisenatide | 11 | $14,341 |
| Anoro ElliptaUmeclidinium Brm/Vilanterol Tr | 27 | $13,069 |
| Lantus SolostarInsulin Glargine,hum.Rec.Anlog | 36 | $4,820 |
| Atorvastatin Calcium | 330 | $3,323 |
| Advair DiskusFluticasone Propion/Salmeterol | 11 | $2,658 |
| Gabapentin | 133 | $2,405 |
| Omeprazole | 92 | $1,928 |
| Amlodipine Besylate | 166 | $1,595 |
| Fluticasone Propionate | 99 | $1,569 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 48 | $1,332 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| PfizerEliquis | $218 | $69,17454 claims |
| Novo NordiskOzempic | $3,007 | $50,94732 claims |
| Boehringer IngelheimJardiance | $555 | $45,87940 claims |
| GSKTrelegy Ellipta, Anoro Ellipta | $61 | $27,74639 claims |
| Sanofi-aventis U.S. LLCSoliqua 100-33, Lantus | $11 | $15,31624 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 902 family medicine providers in Nevada.
Other family medicine in Las Vegas
- Naz WahabLas Vegas$563K
- Jerry CadeLas Vegas$180K
- Warren MagnusLas Vegas$70K
- Kimberly AdamsLas Vegas$51K
- Mandeep GillLas Vegas$24K
- Francis JimenezLas Vegas$20K
- Ryan HuangLas Vegas$18K
- Ma Francesca ChamianLas Vegas$17K
- Leo CapobiancoLas Vegas$17K
- Rogelio MachucaLas Vegas$16K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.